Breaking News

CPHI Milan 2026 Launches Four New Specialist Zones

The 2026 event will feature dedicated areas for AI & Tech, Cold Chain & Logistics, Labelling and Contamination Control.

CPHI Milan 2026 has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the future of healthcare manufacturing and supply chains.

Taking place at the Fiera Milano exhibition center in Rho, Italy, from October 6-8, 2026, the new zones include AI & Tech, Cold Chain & Logistics, Labelling, and Contamination Control. They will provide focused platforms for suppliers, innovators, and solution providers to engage directly with pharmaceutical and biotech decision-makers who are navigating increasing regulatory pressure, digital transformation, supply chain disruption, and rising patient expectations.

“Pharma is evolving rapidly, and innovation increasingly depends on collaboration beyond traditional industry boundaries,” said Tara Dougal, Event Director for CPHI Milan. “These new zones are designed to help companies from adjacent industries showcase their expertise, from AI-driven manufacturing and digital compliance to resilient logistics and next-generation labelling solutions.”

AI & Tech Zone 

This zone will showcase software, digital infrastructure and intelligent technologies driving smarter pharmaceutical operations and commercial performance. Featuring providers across manufacturing optimization, quality management, predictive maintenance, regulatory compliance, CRM platforms, real-world evidence and analytics, the zone will connect pharma manufacturers and CDMOs with technology partners capable of accelerating digital transformation.

Cold Chain & Logistics Zone

As biologics, cell and gene therapies, and temperature-sensitive medicines continue to expand globally, the Cold Chain & Pharma Logistics Zone will focus on the technologies and services supporting compliant, resilient and sustainable pharmaceutical logistics. The zone will bring together providers of temperature-controlled packaging, real-time monitoring technologies, storage solutions, transportation services, and supply chain orchestration platforms supporting modern pharmaceutical distribution.

Labelling Zone 

The Labelling Zone will connect specialist suppliers with pharmaceutical packaging, manufacturing and regulatory teams seeking innovative approaches to compliance, traceability, anti-counterfeiting and patient engagement. From serialization and track-and-trace technologies to smart packaging, e-labelling, RFID solutions and sustainable materials, the zone will highlight the growing role of labelling in improving patient safety and regulatory alignment.

Contamination Control Zone

Driven by stricter global standards and revised EU GMP Annex 1 regulations, the Contamination Control Zone will provide a dedicated platform for suppliers supporting sterile manufacturing, cleanroom operations and contamination risk management. The zone will feature cleanroom specialists, monitoring system providers, containment equipment manufacturers, sterilization technology providers, and compliance consultants helping pharmaceutical companies improve safety, reliability, and operational efficiency.

CPHI Milan has partnered with the International Confederation of Contamination Control Societies (ICCCS) to significantly expand contamination control’s presence and impact at this year’s event and establish it as a long-term industry priority. ICCCS represents contamination control associations and experts across cleanroom technology and pharmaceutical manufacturing hygiene from over 20 countries.

ICCCS will shape certification sessions, technical workshops, and knowledge-sharing forums, while promoting the collaboration to its global network of cleanroom specialists, filtration providers, monitoring system manufacturers, and validation services. The ambition is for 2026 to become the foundation year for a multi-year program, with the success of this initial edition determining deeper collaboration and larger sector-level impact in following years.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters